Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Multiple drugs

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Caorsi R, et al. Relapsing macrophage activation syndrome rescued by treatment with MAS825, an anti-il1 and Il-18 monoclonal antibody, in two patients with systemic onset juvenile idiopathic arthritis. Pediatric Rheumatology 21 (Suppl.): Oct 2023. Available from: URL: https://dx.doi.org/10.1186/s12969-023-00879-8 [abstract] Caorsi R, et al. Relapsing macrophage activation syndrome rescued by treatment with MAS825, an anti-il1 and Il-18 monoclonal antibody, in two patients with systemic onset juvenile idiopathic arthritis. Pediatric Rheumatology 21 (Suppl.): Oct 2023. Available from: URL: https://dx.doi.org/10.1186/s12969-023-00879-8 [abstract]
Metadaten
Titel
Multiple drugs
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57723-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Antineoplastics

Case report

AZD-1222

Case report

Denosumab

Case report

Multiple drugs

Case report

Bevacizumab